Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inoperable Stage I/II Non-small Cell Lung Cancer”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Early research (Phase 1)Study completedNCT00738452
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy

Who this might be right for
Lung Cancer
City of Hope Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT01757288
What this trial is testing

Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC

Who this might be right for
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
University of Texas Southwestern Medical Center 98
Not applicableStudy completedNCT00351962
What this trial is testing

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours

Who this might be right for
Lung NeoplasmsLung Cancer
AHS Cancer Control Alberta 58
Testing effectiveness (Phase 2)Study completedNCT00178256
What this trial is testing

Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
University of Rochester 41
Large-scale testing (Phase 3)Ended earlyNCT00003803
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 158
Testing effectiveness (Phase 2)Study completedNCT00750269
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 120
Large-scale testing (Phase 3)Study completedNCT00253591
What this trial is testing

Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Medical Research Council 500
Testing effectiveness (Phase 2)Study completedNCT00591838
What this trial is testing

A Phase I/II Trial of Stereotactic Body Radiation Therapy

Who this might be right for
Inoperable Stage I/II Non-small Cell Lung Cancer
Washington University School of Medicine 74
Testing effectiveness (Phase 2)Ended earlyNCT00662311
What this trial is testing

Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery

Who this might be right for
Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
University of Washington 5
Testing effectiveness (Phase 2)Study completedNCT00960999
What this trial is testing

Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 94
Early research (Phase 1)Ended earlyNCT00062335
What this trial is testing

High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 14
Testing effectiveness (Phase 2)Ended earlyNCT03233724
What this trial is testing

Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas

Who this might be right for
Carcinoma, Non-Small-Cell LungLung CancerNon-Small Cell Lung Cancer+2 more
National Cancer Institute (NCI) 9
Not applicableUnknownNCT01920789
What this trial is testing

Stereotactic Precision And Conventional Radiotherapy Evaluation

Who this might be right for
Non-small Cell Lung Cancer
Ass. Prof. Jan Nyman 102
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05764928
What this trial is testing

Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

Who this might be right for
Nonsquamous Nonsmall Cell Neoplasm of Lung
Rgene Corporation 32
Large-scale testing (Phase 3)Active Not RecruitingNCT03833154
What this trial is testing

Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 724
Not applicableStudy completedNCT00303901
What this trial is testing

Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery

Who this might be right for
Lung CancerMetastatic Cancer
Barbara Ann Karmanos Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT00843726
What this trial is testing

Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Roswell Park Cancer Institute 98
Not applicableStudy completedNCT00499447
What this trial is testing

Radiofrequency Ablation and External-Beam Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Lung Cancer
Wake Forest University Health Sciences 13
Testing effectiveness (Phase 2)UnknownNCT01795521
What this trial is testing

LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage INon-small Cell Lung Cancer Stage II
European Organisation for Research and Treatment of Cancer - EORTC 39
Testing effectiveness (Phase 2)Study completedNCT00495040
What this trial is testing

Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 38
Next Page